Target intelligence / Profile preview

BLOC1S5-TXNDC5 readthrough (BLOC1S5-TXNDC5)

Target
BLOC1S5-TXNDC5
Molecular classification
lncRNA, readthrough transcript, candidate for nonsense-mediated mRNA decay
01

Overview

BLOC1S5-TXNDC5 readthrough is a non-protein coding RNA generated by read-through transcription between the adjacent *MUTED* (BLOC1S5) and *TXNDC5* genes on chromosome 6[1][7]. The transcript is a candidate for nonsense-mediated mRNA decay and does not produce a protein. While standard gene annotations link it to isomerase activity and organelle biogenesis based on its parental genes, the readthrough itself has no recognized protein function. Disease associations are relevant mainly via functional roles of *BLOC1S5* and *TXNDC5*, not the readthrough transcript. In cancer research, some data identify this RNA as part of a prognostic ferroptosis gene set in breast cancer, suggesting potential use as a disease biomarker, though it is not itself a drug target or functional receptor[5][7]. In summary: BLOC1S5-TXNDC5 readthrough is not a protein-coding gene or therapeutic target, but rather a non-coding RNA with limited known biological and clinical relevance. Most research ties its disease links to parental genes, and its direct functional or pharmacological roles are not established[1][7][5].

Other names
MUTED-TXNDC5BLOC1S5-TXNDC5 readthrough (non-protein coding)MUTED-TXNDC5 readthrough (non-protein coding)BLOC1S5-TXNDC5
02

Mechanism of action

Not applicable (no protein product, not a therapeutic target)

03

Biological functions

Currently, there is no evidence for a direct biological function due to lack of protein product
04

Disease associations

Hermansky-Pudlak syndrome 11 (via neighboring BLOC1S5 gene)Hermansky-Pudlak syndrome 1 (via neighboring TXNDC5 gene)Potential biomarker in cancer (referenced as a conjoined gene associated with ferroptosis-related prognosis in breast cancer)
05

Safety considerations

Not applicable (no direct therapeutic targeting or drug interaction)
06

Interacting drugs

None reported
07

Biomarkers

May serve as a molecular marker for clinical diagnosis or prognosis in certain cancers (as one of the five ferroptosis-related conjoined genes with prognostic value in breast cancer)

Beyond the preview

Go deeper on BLOC1S5-TXNDC5 readthrough (BLOC1S5-TXNDC5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BLOC1S5-TXNDC5 readthrough (BLOC1S5-TXNDC5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call